Fresenius Medical Care AG (FMS) Common Equity (2009 - 2025)

Fresenius Medical Care AG (FMS) has reported Common Equity for 17 consecutive years, with $16.6 billion the latest figure, recorded in Q4 2025.

• In Q4 2025, Common Equity fell 1.33% year-over-year to $16.6 billion; the TTM figure through Dec 2025 stood at $16.6 billion (down 1.33% YoY), while the FY2025 annual figure was $16.6 billion, down 1.33% from the prior year.
• Common Equity came in at $16.6 billion for Q4 2025 at Fresenius Medical Care AG, up from $16.3 billion in the prior quarter.
• The five-year high for Common Equity was $16.9 billion in Q3 2022, with the low at $15.4 billion in Q2 2021.
• Average Common Equity over 5 years is $16.3 billion, with a median of $16.3 billion recorded in 2025.
• Across the five-year window, Common Equity rose 8.77% in 2021 and fell 3.32% in 2024, its largest moves.
• Year by year, Common Equity stood at $16.0 billion in 2021, then declined by 1.44% to $15.8 billion in 2022, then grew by 1.21% to $16.0 billion in 2023, then gained by 5.63% to $16.9 billion in 2024, then retreated by 1.33% to $16.6 billion in 2025.
• According to Business Quant data, Common Equity over the past three periods registered $16.6 billion, $16.3 billion, and $16.2 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.